Flibanserin
Back to searchMolecule Structure
Scientific Name
Flibanserin
Description of the Drug
Flibanserin is a 5-HT receptor modulator used for the treatment of selected premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04908
http://www.drugbank.ca/drugs/DB04908
Brand Name(s)
Addyi
Company Owner(s)
Sprout Pharmaceuticals Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL247579 | |
PharmGKB | PA166153431 | |
Human Metabolome Database | HMDB0252304 | |
DrugBank | DB04908 | |
PubChem: Thomson Pharma | 14805189 | |
PubChem | 6918248 | |
Nikkaji | J672.705K | |
BindingDB | 50476735 | |
DrugCentral | 5022 | |
ChemicalBook | CB91178756 | |
Guide to Pharmacology | 8182 | |
rxnorm | ADDYI | FLIBANSERIN |
PubChem: Drugs of the Future | 12014794 | |
ChEBI | 90865 | |
ZINC | ZINC000052716421 |